Drugs / NAD+
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04604704 | Jan 2021 → Jan 2023 | COVID-19, long COVID-19 | AgelessRx | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NAD+ | “NAD+ will be applied using iontophoresis patches.” NCT04604704 ↗ |
| Route | Topical | “absorption through the skin into the blood.” NCT04604704 ↗ |